“Becoming the first company to supply cannabis to Poland is validation of Aurora’s ability to do business in international markets with high barriers to entry,”
While the tumors are difficult to treat it is hoped that the treatment will slow the growth along with killing the cells.
Suggestions will be finalised and confirmed by 1st December 2018
The licenses being pursued will allow Impression, subject to individual product permit issue, the capacity to capitalise on local and international opportunities
We’ve initiated research projects focusing on not only the clinical effects but also the quality of life for the patients during the pilot programme.
Who decides whether a product is a Medicine or not?
The medical and scientific community should focus on the powerful medicine that the plant offers in her natural form